title: [A report of 9 cases of neurosarcoidosis].
abstract: BACKGROUND
  Neurological involvement in sarcoidosis is rare and highly variable. To date, no consensus was reached about the diagnosis approach. We report a case series of 9 patients with neuosarcoidosis, with favorable outcome under therapy.
  
  
  METHODS
  We examined a case series of 9 patients with neurosarcoidosis. Clinical, radiological, therapeutic features and outcome were studied.
  
  
  RESULTS
  Six of the nine patients were females. Patients' age ranged from 31 to 70 years. Initial neurological symptoms lead to the diagnosis of systemic sarcoidosis in all patients. Central nervous system involvement was found in 77 percent with cranial nerve involvement in 55 percent. Twenty-three percent of patients presented with peripheral neuropathy and 33 percent with meningitis. The diagnosis was definite in 2 patients, probable in one and possible in six others. All patients were given steroid therapy. Total remission was obtained in three and partial remission in three. Three patients remained stable and one died.
  
  
  CONCLUSIONS
  Histological signs are not constant in neurosarcoidosis. The lack of these signs should lead the physician to search for latent extraneurological symptoms which are suggestive of the diagnosis. Nervous biopsy can thus be avoided.
authors.affiliation: Service de Neurologie, Hôpital Militaire Med V, Rabat, Maroc.
authors.forename: A
authors.initials: A
authors.lastname: Karouache
authors.forename: J
authors.initials: J
authors.lastname: Mounach
authors.forename: N
authors.initials: N
authors.lastname: Aziz
authors.forename: A
authors.initials: A
authors.lastname: Bouraza
authors.forename: A
authors.initials: A
authors.lastname: Satte
authors.forename: H
authors.initials: H
authors.lastname: Ouhabi
authors.forename: R
authors.initials: R
authors.lastname: Rafiq
authors.forename: N
authors.initials: N
authors.lastname: Boutaleb
authors.forename: R
authors.initials: R
authors.lastname: Mossadaq
mesh_terms: D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000188:drug therapy / Q000473:pathology*; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology; D004569:Electroencephalography; D004576:Electromyography; D005260:Female; D006801:Humans; D006984:Hypertrophy / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010306:Parotid Gland / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone; D008775:Methylprednisolone